TY  - GEN
AU  - Custodio,A
AU  - Carmona-Bayonas,A
AU  - Jiménez-Fonseca,P
AU  - Sánchez,M L
AU  - Viudez,A
AU  - Hernández,R
AU  - Cano,J M
AU  - Echavarria,I
AU  - Pericay,C
AU  - Mangas,M
AU  - Visa,L
AU  - Buxo,E
AU  - García,T
AU  - Rodríguez Palomo,A
AU  - Álvarez Manceñido,F
AU  - Lacalle,A
AU  - Macias,I
AU  - Azkarate,A
AU  - Ramchandani,A
AU  - Fernández Montes,A
AU  - López,C
AU  - Longo,F
AU  - Sánchez Bayona,R
AU  - Limón,M L
AU  - Díaz-Serrano,A
AU  - Hurtado,A
AU  - Madero,R
AU  - Gómez,C
AU  - Gallego,J
TI  - Nomogram-based prediction of survival in patients with advanced oesophagogastric adenocarcinoma receiving first-line chemotherapy: a multicenter prospective study in the era of trastuzumab
SN  - 1532-1827
PY  - 2017///0822
KW  - Adenocarcinoma
KW  - chemistry
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Ascites
KW  - etiology
KW  - Bone Neoplasms
KW  - secondary
KW  - Esophageal Neoplasms
KW  - Esophagogastric Junction
KW  - Health Status
KW  - Humans
KW  - Lymphocyte Count
KW  - Middle Aged
KW  - Neoplasm Grading
KW  - Neutrophils
KW  - Nomograms
KW  - Receptor, ErbB-2
KW  - analysis
KW  - Stomach Neoplasms
KW  - Survival Rate
KW  - Trastuzumab
KW  - administration & dosage
KW  - Tumor Burden
KW  - White People
KW  - Young Adult
N1  - Publication Type: Journal Article; Multicenter Study; Validation Study
UR  - https://doi.org/10.1038/bjc.2017.122
ER  -